First patient dosed in EXIST Phase 2a study in Parkinson’s disease By Investing.com
STOCKHOLM , Dec. 5, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) introduced at this time that the ...
Tag: dosed
STOCKHOLM , Dec. 5, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) introduced at this time that the ...